234080 — JW Life Science Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareConservativeSmall CapSuper Stock

Annual cashflow statement for JW Life Science, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	21,938	16,867	12,914	14,961	28,144
Depreciation
Amortisation
Non-Cash Items	10,295	25,231	18,358	14,665	3,500
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-19,561	-8,824	-14,328	-30,430	-9,577
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities	24,276	45,497	30,165	14,129	37,574
Capital Expenditures	-8,356	-14,980	-19,396	-8,293	-8,267
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-15	-21,323	-3,409	-19,954	16,303
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-8,371	-36,303	-22,805	-28,247	8,037
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	-18,820	-16,463	-5,029	13,115	-29,308
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-2,915	-7,269	2,331	-1,003	16,302